Publication Date
2-24-2023
Journal
Nature Communications
DOI
10.1038/s41467-023-36678-8
PMID
36828809
PMCID
PMC9958016
PubMedCentral® Posted Date
2-24-2023
PubMedCentral® Full Text Version
Post-Print
Published Open-Access
yes
Keywords
Humans, Genome-Wide Association Study, Cholangitis, Sclerosing, Phenotype, Interferon Regulatory Factors, Polymorphism, Single Nucleotide, Genetic predisposition to disease, Genetic variation, Genome-wide association studies
Abstract
Primary sclerosing cholangitis (PSC) is a rare autoimmune bile duct disease that is strongly associated with immune-mediated disorders. In this study, we implemented multitrait joint analyses to genome-wide association summary statistics of PSC and numerous clinical and epidemiological traits to estimate the genetic contribution of each trait and genetic correlations between traits and to identify new lead PSC risk-associated loci. We identified seven new loci that have not been previously reported and one new independent lead variant in the previously reported locus. Functional annotation and fine-mapping nominated several potential susceptibility genes such as MANBA and IRF5. Network-based in silico drug efficacy screening provided candidate agents for further study of pharmacological effect in PSC.
Included in
Diseases Commons, Epidemiology Commons, Genetic Structures Commons, Medical Genetics Commons, Medical Specialties Commons
Comments
Associated Data